This is a StreetInsider.com Premium Only Page

(TVTX) – SEC Filings

Apr 24, 2024 04:06 PM Form 8-K Travere Therapeutics, For: Apr 24

Apr 12, 2024 04:05 PM Form 4 Travere Therapeutics, For: Apr 11 Filed by: Cline Christopher R.

Mar 27, 2024 04:36 PM Form ARS Travere Therapeutics, For: Dec 31

Mar 27, 2024 04:35 PM Form DEFA14A Travere Therapeutics,

Mar 27, 2024 04:32 PM Form DEF 14A Travere Therapeutics, For: May 08

Feb 23, 2024 04:06 PM Form 8-K Travere Therapeutics, For: Feb 23

Feb 20, 2024 08:12 AM Form 10-K Travere Therapeutics, For: Dec 31

Feb 15, 2024 04:06 PM Form 8-K Travere Therapeutics, For: Feb 15

Feb 14, 2024 02:35 PM Form SC 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC

Feb 14, 2024 08:59 AM Form SC 13G/A Travere Therapeutics, Filed by: Deep Track Capital, LP

Feb 14, 2024 06:39 AM Form SC 13G/A Travere Therapeutics, Filed by: MACQUARIE GROUP LTD

Feb 13, 2024 06:14 PM Form SC 13G/A Travere Therapeutics, Filed by: VANGUARD GROUP INC

Feb 12, 2024 02:58 PM Form SC 13G/A Travere Therapeutics, Filed by: JANUS HENDERSON GROUP PLC

Feb 9, 2024 10:34 AM Form SC 13G Travere Therapeutics, Filed by: MORGAN STANLEY

Feb 7, 2024 07:37 AM Form SC 13G/A Travere Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: Dube Eric M

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: Calvin Sandra

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: Heerma Peter

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: Cline Christopher R.

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: ROTE WILLIAM E.

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: REED ELIZABETH E

Feb 2, 2024 04:06 PM Form 4 Travere Therapeutics, For: Jan 31 Filed by: Inrig Jula

Feb 1, 2024 09:59 PM Form 144 Travere Therapeutics, Filed by: REED ELIZABETH E

Feb 1, 2024 09:59 PM Form 144 Travere Therapeutics, Filed by: ROTE WILLIAM E.

Feb 1, 2024 09:59 PM Form 144 Travere Therapeutics, Filed by: Heerma Peter

Feb 1, 2024 09:58 PM Form 144 Travere Therapeutics, Filed by: Dube Eric M

Feb 1, 2024 12:45 PM Form 144 Travere Therapeutics, Filed by: Dube Eric M

Feb 1, 2024 11:39 AM Form 144 Travere Therapeutics, Filed by: REED ELIZABETH E

Feb 1, 2024 09:52 AM Form 144 Travere Therapeutics, Filed by: ROTE WILLIAM E.

Jan 25, 2024 04:11 PM Form 4 Travere Therapeutics, For: Jan 23 Filed by: REED ELIZABETH E

Jan 25, 2024 04:10 PM Form 4 Travere Therapeutics, For: Jan 23 Filed by: ROTE WILLIAM E.

Jan 25, 2024 04:10 PM Form 4 Travere Therapeutics, For: Jan 23 Filed by: Dube Eric M

Jan 25, 2024 04:10 PM Form 4 Travere Therapeutics, For: Jan 23 Filed by: Heerma Peter

Jan 25, 2024 04:10 PM Form 4 Travere Therapeutics, For: Jan 23 Filed by: Cline Christopher R.

Jan 25, 2024 04:10 PM Form 4 Travere Therapeutics, For: Jan 23 Filed by: Calvin Sandra

Jan 25, 2024 09:24 AM Form SC 13G/A Travere Therapeutics, Filed by: STATE STREET CORP

Jan 24, 2024 09:48 AM Form SC 13G/A Travere Therapeutics, Filed by: BlackRock Inc.

Jan 23, 2024 01:18 PM Form 144 Travere Therapeutics, Filed by: Dube Eric M

Jan 23, 2024 10:53 AM Form 144 Travere Therapeutics, Filed by: REED ELIZABETH E

Jan 23, 2024 10:51 AM Form 144 Travere Therapeutics, Filed by: ROTE WILLIAM E.

Jan 8, 2024 07:08 AM Form 8-K Travere Therapeutics, For: Jan 08

Jan 5, 2024 04:12 PM Form 4 Travere Therapeutics, For: Jan 03 Filed by: Inrig Jula

Dec 4, 2023 04:10 PM Form 8-K Travere Therapeutics, For: Nov 30

Nov 7, 2023 05:15 PM Form 10-Q Travere Therapeutics, For: Sep 30

Nov 7, 2023 04:05 PM Form 8-K Travere Therapeutics, For: Nov 07

Oct 6, 2023 02:36 PM Form SC 13G/A Travere Therapeutics, Filed by: BlackRock Inc.

Oct 4, 2023 04:05 PM Form 4 Travere Therapeutics, For: Oct 03 Filed by: Heerma Peter

Sep 21, 2023 07:36 AM Form 8-K Travere Therapeutics, For: Sep 21

Sep 7, 2023 05:01 PM Form 8-K/A Travere Therapeutics, For: Aug 31

Sep 5, 2023 08:16 PM Form 4 Travere Therapeutics, For: Sep 05 Filed by: Cline Christopher R.